Cardiac Biomarkers Market Analysis: Emerging Technologies and Forecast
The Cardiac Biomarkers Market is led by North America, which held more than 44.79% of global revenue in 2024. The region benefits from advanced healthcare infrastructure, widespread adoption of diagnostic technologies, and high demand for cardiovascular testing. Europe represents another important regional market, supported by established research institutions, healthcare systems, and...
0 Comments 0 Shares 74 Views 0 Reviews